lectura de vasculitis.pdf
Post on 05-Dec-2014
27 Views
Preview:
TRANSCRIPT
Harrison’s Lecture Notes
Copyright © The McGraw-Hill Companies. All rights reserved.
Vasculitis
Carol A. Langford, MD, MHS
Director, Center for Vasculitis Care and Research
Department of Rheumatic and Immunologic Diseases
Cleveland Clinic Foundation
Harrison’s Lecture Notes
Copyright © The McGraw-Hill Companies. All rights reserved.
Lecture Rationale and Objectives
Lecture Rationale: • The vasculitic diseases are uncommon entities that often present first to internists and family medicine physicians
• Suspicion is essential because certain forms of vasculitis
are organ and life threatening
• Recognition and early diagnosis of vasculitis plays an important
role in preventing morbidity and even mortality
Lecture Objectives: • Identify the spectrum of the vasculitic diseases
• Recognize the clinical manifestations of vasculitis
• Develop a diagnostic approach to vasculitis
Harrison’s Lecture Notes
Copyright © The McGraw-Hill Companies. All rights reserved.
Blood vessel damage
Thickening of vessel wall Attenuation of vessel wall
Aneurysm formation or
Disruption of the vessel wall
with hemorrhage into tissue
Tissue or organ ischemia
Luminal narrowing
or occlusion Vessel wall thinning
Vasculitis = Inflammation of the Blood Vessel
Harrison’s Lecture Notes
Copyright © The McGraw-Hill Companies. All rights reserved.
Vasculitis: Histological and Clinical Correlation
Palpable Purpura Disruption of the vessel wall with
red blood cell extravasation into tissue
Copyright © The McGraw-Hill Companies, Inc. All
rights reserved.
Courtesy of Carol A. Langford
Harrison’s Lecture Notes
Copyright © The McGraw-Hill Companies. All rights reserved.
Giant cell arteritis
Takayasu’s arteritis
Kawasaki disease
Polyarteritis nodosa
Wegener’s granulomatosis
Microscopic polyangiitis
Churg-Strauss syndrome
Henoch-Schönlein purpura
Medications
Infection
Malignancy
Transplant
Cryoglobulinemia
Connective tissue disease
(Rheumatoid arthritis, SLE
Inflammatory myositis)
Primary Vasculitides Secondary Vasculitides
Vasculitis occurring secondary to an underlying disease or exposure
Unique disease entities without a currently identified underlying cause
where vasculitis forms the pathological basis of tissue injury
Vasculitis Is Not One Specific Disease
Blood vessel inflammation can be seen in a variety of settings
Harrison’s Lecture Notes
Copyright © The McGraw-Hill Companies. All rights reserved.
How Do Forms of Primary Vasculitis Differ?
Epidemiology: Age, sex, ethnicity, frequency
Clinical Manifestations: Symptoms, signs
Patterns of organ involvement
Diagnosis: Clinical and laboratory features
Biopsy (granulomas, eosinophils)
Arteriography
Treatment and Outcome: Supportive care and close observation
Prednisone
Cytotoxic therapy (cyclophosphamide)
Predominant vessel size: Large, medium, small vessel
Harrison’s Lecture Notes
Copyright © The McGraw-Hill Companies. All rights reserved.
Large Vessel
Giant cell arteritis
Takayasu’s arteritis
Medium Vessel
Polyarteritis nodosa
Kawasaki disease
Small Vessel
Wegener’s granulomatosis
Microscopic polyangiitis
Churg-Strauss syndrome
Henoch-Schönlein purpura
Isolated cutaneous vasculitis
Aorta Capillary Vein
Vessel size plays a role in: Symptoms and signs
Methods of diagnostic evaluation
Harrison’s Lecture Notes
Copyright © The McGraw-Hill Companies. All rights reserved.
Large Vessel Vasculitis
Aorta, main branches of the aorta, pulmonary arteries
Aortic aneurysm Subclavian artery stenosis
Courtesy of Carol A. Langford
Courtesy of Carol A. Langford
Harrison’s Lecture Notes
Copyright © The McGraw-Hill Companies. All rights reserved.
Large Vessel Vasculitis: Giant Cell Arteritis
(Historically also called temporal arteritis)
• The most common form of primary systemic vasculitis
• Granulomatous large vessel vasculitis
• Occurs in people over the age of 50 (mean age 74)
• 2:1 women:men
• Preferentially involves extracranial branches of the carotid artery
Harrison’s Lecture Notes
Copyright © The McGraw-Hill Companies. All rights reserved.
Giant Cell Arteritis
Clinical Features:
• Headache, Scalp tenderness, jaw / tongue claudication
• Visual loss due to optic nerve ischemia from arteritis of ocular vessels
• Fever, fatigue, weight loss
• Polymyalgia rheumatica: pain along shoulder and hip girdle
• Extremity claudication
• Aortic aneurysm
• Nodular, tender, temporal artery with diminished or absent pulsation
• Scalp ischemia
• Absent peripheral pulses, asymmetry of blood pressure in extremities
27% of patients with GCA will have
non-cranial large vessel disease
Physical examination:
Harrison’s Lecture Notes
Copyright © The McGraw-Hill Companies. All rights reserved.
Giant Cell Arteritis
Laboratories:
Diagnosed by:
Reflective of an inflammatory process:
• CBC: anemia, thrombocytosis, leukocytosis
• Elevated erythrocyte sedimentation rate (ESR), C-reactive protein
Temporal artery biopsy
(+) 50-80%
Courtesy of Carol A. Langford
Harrison’s Lecture Notes
Copyright © The McGraw-Hill Companies. All rights reserved.
Giant Cell Arteritis
• Prednisone 40-60 mg daily - Reduces symptoms and prevents visual loss
- Begin immediately while biopsy is being arranged
Treatment:
Outcome:
• 70% relapse require increased prednisone
• 35-85% have prednisone side effects
• Overall no difference in survival
• 18x higher rate of thoracic aortic aneurysms
- May occur as a late complication of disease
- Associated with a high mortality rate
• Aspirin 81 mg daily - May reduce cranial ischemic complications
- Use in all patients without contraindications Courtesy of Carol A. Langford
Harrison’s Lecture Notes
Copyright © The McGraw-Hill Companies. All rights reserved.
Medium Vessel Vasculitis
Vessel examples: GI tract, nerve, digits, interlobular renal
Mesenteric Arteriogram
Microaneurysms, stenoses, beading
Biopsy
Vessel supplying sural nerve
Courtesy of Carol A. Langford Copyright © The McGraw-Hill Companies, Inc. All rights reserved.
Harrison’s Lecture Notes
Copyright © The McGraw-Hill Companies. All rights reserved.
Medium Vessel Vasculitis: Polyarteritis Nodosa
• First form of vasculitis described
– Systemic features
– Nerve
– Renal
– GI tract
– Digital infarction
Fever, weight loss, arthralgias, night sweats
Mononeuritis multiplex (ie: foot drop, wrist drop)
Hypertension, infarction
Pain, infarction, perforation, bleeding
Ischemic finger / toe
Often presents with acute severe disease
Clinical Features:
Harrison’s Lecture Notes
Copyright © The McGraw-Hill Companies. All rights reserved.
Polyarteritis Nodosa
Laboratories:
Diagnosed by:
Treatment:
Elevated ESR
Anemia, mild elevations in WBC and platelets
May see LFT abnormalities, microscopic hematuria
A PAN-like vasculitis can occur with hepatitis B or C
Arteriography, biopsies
Prednisone + cyclophosphamide
Prednisone alone for non-severe disease
Antiviral treatment if hepatitis B or C are present
Harrison’s Lecture Notes
Copyright © The McGraw-Hill Companies. All rights reserved.
Small Vessel Vasculitis
Capillary, arteriole, venule
Alveolar hemorrhage Glomerulonephritis Copyright © The McGraw-Hill Companies, Inc. All rights reserved.
Courtesy of Carol A. Langford Courtesy of Carol A. Langford
Courtesy of Carol A. Langford
Harrison’s Lecture Notes
Copyright © The McGraw-Hill Companies. All rights reserved.
Small Vessel Vasculitis: Wegener’s Granulomatosis
Sinus (>95%) Lung (85%) Kidney (80%)
Proteinuria,
Hematuria
Red blood cell casts
Detected by urinalysis:
20% at diagnosis
80% during course
Can be rapidly progressive
Typically asymptomatic
May lead to renal failure
Courtesy of Carol A. Langford
Courtesy of Carol A. Langford
Courtesy of Carol A. Langford
Harrison’s Lecture Notes
Copyright © The McGraw-Hill Companies. All rights reserved.
Antineutrophil Cytoplasmic Antibodies (ANCA)
Myeloperoxidase (MPO) Proteinase 3 (PR3)
cANCA
cytoplasmic staining
pANCA
perinuclear staining
Target Antigens
In Vasculitis
PR3-ANCA MPO-ANCA
Wegener’s granulomatosis
Microscopic polyangiitis
Churg-Strauss syndrome
75-90% 5-20% up to 20%
10-50% 50-80% up to 20%
3-20% 2-40% up to 60%
ANCA (-)
Courtesy of Carol A. Langford Courtesy of Carol A. Langford
Harrison’s Lecture Notes
Copyright © The McGraw-Hill Companies. All rights reserved.
Key Clinical Issues Regarding ANCA
• Can ANCA be used to diagnose Wegener’s granulomatosis?
Usually no – because of the toxicity of therapy and the need for
diagnostic precision biopsy still required in most people
• Do high ANCA levels indicate active vasculitis?
No - In large cohorts, ANCA levels are higher overall in active disease
but…..
In individual patients ANCA does not correlate with disease activity
and should not be used alone to guide treatment
ANCA can be helpful but is not necessary for diagnosis
Harrison’s Lecture Notes
Copyright © The McGraw-Hill Companies. All rights reserved.
Wegener’s Granulomatosis
Diagnosed by:
Treatment:
Typically biopsy
Prednisone + cyclophosphamide
Prednisone + methotrexate (non-severe disease)
Outcome: Survival: Untreated: 5 months
Treatment: 80% survival
Challenges: Damage from prior disease
Treatment related toxicity
50-70% relapse
Harrison’s Lecture Notes
Copyright © The McGraw-Hill Companies. All rights reserved.
Small Vessel Vasculitis: Cutaneous Vasculitis
Cutaneous vasculitis represents the most common
vasculitic manifestation encountered in clinical practice
Copyright © The McGraw-Hill Companies, Inc. All rights reserved.
Harrison’s Lecture Notes
Copyright © The McGraw-Hill Companies. All rights reserved.
Small Vessel Vasculitis: Cutaneous Vasculitis
< 30% no identified cause or disease outside of the skin
• Medication
• Infection
• Malignancy
• Connective tissue disease
• Heralding feature of a primary systemic vasculitis
> 70% occur in the setting of an underlying process:
Treatment of isolated cutaneous vasculitis:
• Do not overtreat: recognize that this is not threatening
• Avoid the use of toxic immunosuppressive agents
Harrison’s Lecture Notes
Copyright © The McGraw-Hill Companies. All rights reserved.
You see a patient with a possible cutaneous vasculitis
What do you need to do?
1. Recognize if a patient is in a potentially threatening situation
2. Confirm that this is vasculitis
3. Determine if there is an underlying cause for the vasculitis
How do you do this?
Harrison’s Lecture Notes
Copyright © The McGraw-Hill Companies. All rights reserved.
Recognition of Vasculitis
Skin + +
Eye + +
ENT + + +
Lung + / - + / - +
Kidney +
GI + + + +
Neuro + + +
History Exam Labs Imaging
Harrison’s Lecture Notes
Copyright © The McGraw-Hill Companies. All rights reserved.
Assessment of Vasculitis
• Do a complete review of systems
• Medications: includes over-the-counter, supplements, recreational drugs
History
Physical Examination
• Provides clues of organ involvement, features of an underlying disease
Laboratories
Urinalysis (if (+) blood, check their creatinine immediately)
Chemistries (to include creatinine and hepatic)
CBC with differential
ESR, CRP
Always
Perform
Systemic vasculitis
Connective tissue disease
Infection
Neoplasm
Pursue additional lab testing if
there are features that point towards:
Harrison’s Lecture Notes
Copyright © The McGraw-Hill Companies. All rights reserved.
Assessment of Vasculitis
Imaging
Chest imaging (CXR, CT)
Pursue CT, MRI, arteriography of other sites as clinically indicated
• Perform in all patients with pulmonary symptoms
• No pulmonary symptoms: obtain imaging if there are other features
that suggest a systemic small vessel vasculitis
Biopsy
• Lesions that looks like vasculitis may not be
• If disease is outside of the skin, these are usually better locations
for biopsy to confirm a systemic vasculitis
Harrison’s Lecture Notes
Copyright © The McGraw-Hill Companies. All rights reserved.
Recognizing Vasculitis: Suspicion is the Key
Any instance of:
• Palpable purpura
• Pulmonary hemorrhage
• Glomerulonephritis
• Ischemic digits
• Mononeuritis multiplex (wrist or foot drop)
• Worsening sinus symptoms not responsive to treatment
• Unexplained multisystem disease
• Unexplained pulmonary infiltrates
• Rapidly progressive major organ dysfunction
Consider also in the setting of:
Harrison’s Lecture Notes
Copyright © The McGraw-Hill Companies. All rights reserved.
What to do if a Vasculitis is Suspected
• Rule out potentially organ- or life-threatening disease
- Remember asymptomatic kidney and lung disease
• Categorize where possible to a specific disease entity
- Consider pattern of features
• Pursue means of a definitive diagnosis • Select treatment based upon diagnosis and its severity • Seek out consultation early as directed by clinical features
Further information on vasculitis can be found in: Harrison’s Principles of Internal Medicine, 17e
Chapter 319: The Vasculitis Syndromes
By Carol A. Langford and Anthony S. Fauci
Harrison’s Lecture Notes
Copyright © The McGraw-Hill Companies. All rights reserved.
Terms of Use: Harrison’s Lecture Notes
PowerPoint Usage Guidelines
AccessMedicine users may display, download, or print out PowerPoint slides and images
associated with the site for personal and educational use only. Educational use refers to
classroom teaching, lectures, presentations, rounds, and other instructional activities, such
as displaying, linking to, downloading, printing and making and distributing multiple copies of
said isolated materials in both print and electronic format. Users will only display, distribute,
or otherwise make such PowerPoint slides and images from the applicable AccessMedicine
materials available to students or other persons attending in-person presentations, lectures,
rounds or other similar instructional activities presented or given by User.
Commercial use of the PowerPoint slides and images are not permitted under this
agreement. Users may modify the content of downloaded PowerPoint slides only for
educational (non-commercial) use, however the source and attribution may not be modified.
Users may not otherwise copy, print, transmit, rent, lend, sell or modify any images from
AccessMedicine or modify or remove any proprietary notices contained therein, or create
derivative works based on materials therefrom. They also many not disseminate any portion
of the applicable AccessMedicine site subscribed to hereunder through electronic means
except as outlined above, including mail lists or electronic bulletin boards.
top related